In the process of making an item of PPE available for its intended use, a company may produce and sell items – e.g. minerals extracted in the process of constructing an underground mine or oil and gas from testing wells before starting production.
To address diversity in practice, the International Accounting Standards Board (the Board) has amended IAS 16 Property, Plant and Equipment to provide guidance on the accounting for such sale proceeds and the related production costs.
Isolating the costs of production may be challenging in practice. It may require monitoring of costs not previously required by IAS 16 and more extensive estimation and judgement.
Sale proceeds no longer deducted from the cost of PPE before its intended use
Under the amendments, proceeds from selling items before the related item of PPE is available for use should be recognised in profit or loss, together with the costs of producing those items. IAS 2 Inventories should be applied in identifying and measuring these production costs.
Companies will therefore need to distinguish between:
- costs associated with producing and selling items before the item of PPE is available for use; and
- costs associated with making the item of PPE available for its intended use.
Making this allocation of costs may require significant estimation and judgement. Companies in the extractive industry may need to monitor costs at a more granular level.
The meaning of testing the functioning of PPE
Additional disclosure requirements
No disclosure requirements have been added to IAS 16 for sales of items that are an output of a company’s ordinary activities: the disclosure requirements of IFRS 15 Revenue from Contracts with Customers and IAS 2 will apply in such cases.
However, for the sale of items that are not part of a company’s ordinary activities, the amendments require the company to:
- disclose separately the sales proceeds and related production cost recognised in profit or loss; and
- specify the line items in which such proceeds and costs are included in the statement of comprehensive income.
This disclosure is not required if such proceeds and cost are presented separately in the statement of comprehensive income.
Next steps – Transition and effective date
The amendments apply retrospectively, but only to items of PPE made available for use on or after the beginning of the earliest period presented in the financial statements in which the company first applies the amendments.
Although the amendments are not effective until 2022, companies will need to consider including IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors1 disclosures in their next annual financial statements.
1 Paragraphs 30-31 of IAS 8
© 2021 KPMG IFRG Limited, a UK company, limited by guarantee. All rights reserved.